Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening

Journal session
Chairs: R. Costello (Dublin 9, Ireland), R. Duarte (Porto, Portugal)
Aims: to provide an update on antibiotic therapy for idiopathic pulmonary fibrosis (IPF), management of refractory dyspnoea in patients with severe chronic obstructive pulmonary disease (COPD) and patient selection strategies for lung cancer screening with low-dose computed tomography (CT).

Role of the microbiome and antibiotic therapy in IPF A. Wilson (Norwich (Norfolk), United Kingdom)
Management of refractory dyspnoea in COPD D. Janssen (Horn, Netherlands)
Update on lung cancer screening with low-dose CT R. Meza (Ann Arbor, United States of America)
Pulmonary embolism in patients with COPD F. Couturaud (Brest, France)
Discussion and Q&A